Sean Dodge

Stock Analyst at RBC Capital

(2.18)
# 2,900
Out of 5,044 analysts
131
Total ratings
37.11%
Success rate
-1%
Average return

Stocks Rated by Sean Dodge

Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7$6
Current: $3.38
Upside: +77.51%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3$3.5
Current: $0.91
Upside: +283.14%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $218.13
Upside: +23.78%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11$12
Current: $8.36
Upside: +43.54%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $177.73
Upside: +47.98%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20$17
Current: $7.41
Upside: +129.42%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24$32
Current: $23.41
Upside: +36.69%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7$6
Current: $21.04
Upside: -71.48%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100$105
Current: $95.15
Upside: +10.35%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $16.56
Upside: +2.66%
Maintains: Outperform
Price Target: $31$34
Current: $39.49
Upside: -13.90%
Reiterates: Outperform
Price Target: $14
Current: $19.52
Upside: -28.28%
Reiterates: Outperform
Price Target: $10
Current: $3.66
Upside: +173.22%
Reiterates: Outperform
Price Target: $28
Current: $25.93
Upside: +7.98%
Maintains: Outperform
Price Target: $15$14
Current: $19.23
Upside: -27.20%
Initiates: Outperform
Price Target: $33
Current: $180.25
Upside: -81.69%